A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients. Issue 12 (20th July 2014)
- Record Type:
- Journal Article
- Title:
- A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients. Issue 12 (20th July 2014)
- Main Title:
- A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients
- Authors:
- Li Pira, Giuseppina
Ivaldi, Federico
Starc, Nadia
Landi, Fabiola
Rutella, Sergio
Locatelli, Franco
Sacchi, Nicoletta
Tripodi, Gino
Manca, Fabrizio - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="trf12754-sec-0001" sec-type="section"> <title>Background</title> <p>Virus‐specific CD4 and CD8 T lymphocytes from HLA‐matched donors are effective for treatment and prophylaxis of viral infections in immune‐compromised recipients of hematopoietic stem cell transplant recipients. Adoptive immune reconstitution is based on selection of specific T cells or on generation of specific T‐cell lines from the graft donor. Unfortunately, the graft donor is not always immune to the relevant pathogen or the graft donor may not be available (registry‐derived or cord blood donors).</p> </sec> <sec id="trf12754-sec-0002" sec-type="section"> <title>Study Design and Methods</title> <p>Since the possibility of using T cells from a third‐party subject is now established, we screened potential donors for T‐cell responses against cytomegalovirus (CMV), Epstein‐Barr virus (EBV), and adenovirus, the viruses most frequently targeted by adoptive immune reconstitution. Specific T‐cell responses against viral antigens were analyzed in 111 donors using a miniaturized interferon‐γ release assay.</p> </sec> <sec id="trf12754-sec-0003" sec-type="section"> <title>Results</title> <p>Responders to CMV were 64%, to EBV 40%, and to adenovirus 51%. Simultaneous responders to the three viruses were 49%. CMV‐specific CD4 and CD8 T‐cell lines could be generated from 11 of 12 donors defined as positive responders<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="trf12754-sec-0001" sec-type="section"> <title>Background</title> <p>Virus‐specific CD4 and CD8 T lymphocytes from HLA‐matched donors are effective for treatment and prophylaxis of viral infections in immune‐compromised recipients of hematopoietic stem cell transplant recipients. Adoptive immune reconstitution is based on selection of specific T cells or on generation of specific T‐cell lines from the graft donor. Unfortunately, the graft donor is not always immune to the relevant pathogen or the graft donor may not be available (registry‐derived or cord blood donors).</p> </sec> <sec id="trf12754-sec-0002" sec-type="section"> <title>Study Design and Methods</title> <p>Since the possibility of using T cells from a third‐party subject is now established, we screened potential donors for T‐cell responses against cytomegalovirus (CMV), Epstein‐Barr virus (EBV), and adenovirus, the viruses most frequently targeted by adoptive immune reconstitution. Specific T‐cell responses against viral antigens were analyzed in 111 donors using a miniaturized interferon‐γ release assay.</p> </sec> <sec id="trf12754-sec-0003" sec-type="section"> <title>Results</title> <p>Responders to CMV were 64%, to EBV 40%, and to adenovirus 51%. Simultaneous responders to the three viruses were 49%. CMV‐specific CD4 and CD8 T‐cell lines could be generated from 11 of 12 donors defined as positive responders according to the T‐cell assay.</p> </sec> <sec id="trf12754-sec-0004" sec-type="section"> <title>Conclusions</title> <p>These data demonstrate that a large fraction of volunteers can be recruited in a donor registry for selection or expansion of virus specific T cells and that our T‐cell assay predicts the donors' ability to give rise to established T‐cell lines endowed with proliferative potential and effector function for adoptive immune reconstitution.</p> </sec> </abstract> … (more)
- Is Part Of:
- Transfusion. Volume 54:Issue 12(2014)
- Journal:
- Transfusion
- Issue:
- Volume 54:Issue 12(2014)
- Issue Display:
- Volume 54, Issue 12 (2014)
- Year:
- 2014
- Volume:
- 54
- Issue:
- 12
- Issue Sort Value:
- 2014-0054-0012-0000
- Page Start:
- 3145
- Page End:
- 3154
- Publication Date:
- 2014-07-20
- Subjects:
- Hematology -- Periodicals
Blood -- Transfusion -- Periodicals
Blood Group Antigens -- Periodicals
Blood Preservation -- Periodicals
Blood Transfusion -- Periodicals
615 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1537-2995 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=trf ↗
http://www.transfusion.org ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/trf.12754 ↗
- Languages:
- English
- ISSNs:
- 0041-1132
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9020.704000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3822.xml